Skip to main content

Table 2 Least Squares mean percent change from baseline (95% confidence interval) in lipids, lipoproteins and hs-CRP

From: Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects

  

LDL-C

TC

TG

HDL-C

non-HDL-C

Apo B

Apo A-I

hs-CRP

Non-obese

EZ/Simva (n = 77)

−25.2

−13.9

−4.8

1.8

−19.9

−16.6

2.0

−7.1

Doubling statin (n = 42)

−4.9

−4.1

−5.3

−0.2

−4.8

−5.6

−2.3

−3.7

Rosuva 10 (n = 42)

−17.4

−9.4

−2.0

2.6

−13.9

−11.6

1.3

−10.1

Obese

EZ/Simva (n = 237)

−21.6

−12.7

−6.1

1.2

−17.3

−13.7

−0.4

−1.5

Doubling statin (n = 117)

−10.7

−5.3

−0.8

1.8

−8.2

−8.0

0.0

1.1

 

Rosuva 10 (n = 249)

−20.7

−11.4

−4.2

1.6

−16.1

−12.3

0.6

−9.7